DK1812797T3 - Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme - Google Patents
Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdommeInfo
- Publication number
- DK1812797T3 DK1812797T3 DK05818382.3T DK05818382T DK1812797T3 DK 1812797 T3 DK1812797 T3 DK 1812797T3 DK 05818382 T DK05818382 T DK 05818382T DK 1812797 T3 DK1812797 T3 DK 1812797T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- compositions
- treatment
- methods
- hyperproliferative diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003463 hyperproliferative effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62319704P | 2004-10-28 | 2004-10-28 | |
| PCT/US2005/039303 WO2006078336A2 (en) | 2004-10-28 | 2005-10-28 | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1812797T3 true DK1812797T3 (da) | 2013-05-21 |
Family
ID=36692680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05818382.3T DK1812797T3 (da) | 2004-10-28 | 2005-10-28 | Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1812797B1 (da) |
| JP (1) | JP4982377B2 (da) |
| AU (1) | AU2005325227B2 (da) |
| CA (1) | CA2581061C (da) |
| DK (1) | DK1812797T3 (da) |
| ES (1) | ES2410866T3 (da) |
| PL (1) | PL1812797T3 (da) |
| PT (1) | PT1812797E (da) |
| SI (1) | SI1812797T1 (da) |
| WO (1) | WO2006078336A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7794713B2 (en) * | 2004-04-07 | 2010-09-14 | Lpath, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| US7862812B2 (en) * | 2006-05-31 | 2011-01-04 | Lpath, Inc. | Methods for decreasing immune response and treating immune conditions |
| US8444970B2 (en) * | 2006-10-27 | 2013-05-21 | Lpath, Inc. | Compositions and methods for treating ocular diseases and conditions |
| PT2087002E (pt) * | 2006-10-27 | 2014-11-26 | Lpath Inc | Composições e métodos para a ligação de esfingosina-1- fosfato |
| WO2008154470A1 (en) * | 2007-06-08 | 2008-12-18 | University Of Connecticut | Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye |
| WO2017015334A1 (en) * | 2015-07-21 | 2017-01-26 | Saint Louis University | Compositions and methods for diagnosing and treating endometriosis-related infertility |
| CN109328018A (zh) | 2016-12-15 | 2019-02-12 | 雀巢产品技术援助有限公司 | 调节伴侣动物体内的磷或酶的组合物和方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260288A (en) * | 1992-04-03 | 1993-11-09 | The Biomembrane Institute | Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives |
| JPH09176083A (ja) * | 1995-12-28 | 1997-07-08 | Sankyo Co Ltd | 新規化合物ｆ−１２５０９ａ |
| US6423527B1 (en) * | 1997-09-29 | 2002-07-23 | Children's Hospital Medical Center Of Northern California | Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| DK1091745T3 (da) * | 1998-06-29 | 2008-12-15 | Los Angeles Childrens Hospital | Behandling af hyperproliferative forstyrrelser |
| AUPQ744700A0 (en) * | 2000-05-11 | 2000-06-01 | Medvet Science Pty. Ltd. | A method of treatment and agents useful for same |
| AU2001288563A1 (en) * | 2000-08-31 | 2002-03-13 | University Of Connecticut | Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| US6858383B2 (en) * | 2000-12-22 | 2005-02-22 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| US7674580B2 (en) * | 2002-01-17 | 2010-03-09 | Children's Hospital & Research Center At Oakland | Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| PL372103A1 (en) * | 2002-05-16 | 2005-07-11 | Novartis Ag | Use of edg receptor binding agents in cancer |
-
2005
- 2005-10-28 ES ES05818382T patent/ES2410866T3/es not_active Expired - Lifetime
- 2005-10-28 SI SI200531702T patent/SI1812797T1/sl unknown
- 2005-10-28 WO PCT/US2005/039303 patent/WO2006078336A2/en not_active Ceased
- 2005-10-28 EP EP05818382A patent/EP1812797B1/en not_active Expired - Lifetime
- 2005-10-28 PL PL05818382T patent/PL1812797T3/pl unknown
- 2005-10-28 DK DK05818382.3T patent/DK1812797T3/da active
- 2005-10-28 JP JP2007539258A patent/JP4982377B2/ja not_active Expired - Fee Related
- 2005-10-28 CA CA2581061A patent/CA2581061C/en not_active Expired - Fee Related
- 2005-10-28 AU AU2005325227A patent/AU2005325227B2/en not_active Ceased
- 2005-10-28 PT PT58183823T patent/PT1812797E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1812797A2 (en) | 2007-08-01 |
| EP1812797B1 (en) | 2013-03-20 |
| WO2006078336A2 (en) | 2006-07-27 |
| PT1812797E (pt) | 2013-05-21 |
| EP1812797A4 (en) | 2009-04-29 |
| CA2581061A1 (en) | 2006-07-27 |
| PL1812797T3 (pl) | 2013-08-30 |
| AU2005325227A1 (en) | 2006-07-27 |
| JP4982377B2 (ja) | 2012-07-25 |
| HK1102626A1 (en) | 2007-11-30 |
| JP2008518946A (ja) | 2008-06-05 |
| CA2581061C (en) | 2014-09-02 |
| AU2005325227B2 (en) | 2012-11-01 |
| WO2006078336A3 (en) | 2006-11-30 |
| SI1812797T1 (sl) | 2013-06-28 |
| ES2410866T3 (es) | 2013-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| DK1853271T3 (da) | Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme | |
| DK1888033T3 (da) | Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme | |
| DK1628530T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis | |
| DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
| DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
| DK1679058T3 (da) | Farmaceutisk sammensætning til behandling af kardiovaskulære og cerebrovaskulære sygdomme | |
| IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
| DK2952178T3 (da) | Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne | |
| PL2878297T3 (pl) | Leki do leczenia lub zapobiegania chorobom zwłóknieniowym | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1771201T3 (da) | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom | |
| DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
| DK2463283T3 (da) | Kondenserede heterocykliske phenylamidoforbindelser til forebyggelse og behandling af glucokinase-medierede sygdomme | |
| IS8597A (is) | Samsetningar rísedrónats og aðferðir við notkun þess | |
| IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
| DK2063881T3 (da) | Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer | |
| DK1701944T3 (da) | 2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme | |
| IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
| DK1896077T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme | |
| DK1750713T3 (da) | Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner | |
| DK1589973T4 (da) | Formulering og fremgangsmåder til behandling af thrombocytæmi | |
| ZA200703087B (en) | Methods and compositions for the treatment of hyperlipidemia | |
| EP1786265A4 (en) | NEW COMPOSITIONS AND PROCESSING METHODS | |
| DK1611890T3 (da) | Fremgangsmåde til evaluering og behandling af cancer |